Cancer-Associated Fibroblast-Derived FGF7 Promotes Clear Cell Renal Cell Carcinoma Progression and Macrophage Infiltration
Cells · 05.11.2024 · 13 (22) · 1824
DOI: 10.3390/cells13221824 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cells, online erschienen am 05.11.2024. Verfasst von Man Jia und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biochemistry and Molecular Biology, School of Basic Medical Sciences, Southwest Medical University, Luzhou 646000, China. Hauptthemen laut MEDLINE: Carcinoma, Renal Cell, Cancer-Associated Fibroblasts, Kidney Neoplasms, Macrophages. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 34 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Sichuan Science and Technology Program, Science and Technology Program of Luzhou, Key Research and Development Program of Xuzhou City.
Abstract (Originalsprache)
As the predominant stromal cells in the ccRCC surrounding environment, cancer-associated fibroblasts (CAFs) have been established as supportive of tumor growth. However, the detailed molecular mechanisms underlying the supporting role of CAFs in ccRCC have not been well characterized. Evidence from the clustering consensus analysis, single-cell analysis, and the experimental results illustrate that CAF-derived FGF7 plays a crucial role as a signaling mediator between CAFs and ccRCC tumor cells. Mechanistically, CAF-derived FGF7 triggers AKT activation to promote cell growth and cell invasion of ccRCC tumor cells. As a response, ccRCC tumor cells stimulate STAT3-mediated transcriptional regulation, directly increasing FGF7 expression at the chromatin level in CAFs. Moreover, there exists a positive clinical correlation between the abundance of CAFs, FGF7 expression, and the infiltration of M2 type macrophages. The RENCA in vivo mouse model also confirmed that FGF7 depletion could impede RCC development by reducing the recruitment of M2 type macrophages. Overall, this study delineates a key signaling axis governing the crosstalk between CAFs and ccRCC tumor cells, highlighting FGF7 as a promising therapeutic target of ccRCC.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Biochemistry and Molecular Biology, School of Basic Medical Sciences, Southwest Medical University, Luzhou 646000, China.
- Department of Genetics, Xuzhou Medical University, Xuzhou 221004, China.
ORCID-Profile: Ronghao Wang
Förderung
- Sichuan Science and Technology Program
- Science and Technology Program of Luzhou
- Key Research and Development Program of Xuzhou City
- Southwest Medical University Program
Zitieren
APA
Jia, M., Xie, M., Luo, X., Wang, H., Duan, C., Lai, W., Dai, R., & Wang, R. (2024). Cancer-Associated Fibroblast-Derived FGF7 Promotes Clear Cell Renal Cell Carcinoma Progression and Macrophage Infiltration. Cells, 13(22), 1824. https://doi.org/10.3390/cells13221824
Vancouver
Jia M, Xie M, Luo X, Wang H, Duan C, Lai W, et al. Cancer-Associated Fibroblast-Derived FGF7 Promotes Clear Cell Renal Cell Carcinoma Progression and Macrophage Infiltration. Cells. 2024;13(22):1824. doi:10.3390/cells13221824
BibTeX
@article{Jia2024,
author = {Jia, Man and Xie, Mingyu and Luo, Xixi and Wang, Huiping and Duan, Chunyan and Lai, Wanni and Dai, Rongyang and Wang, Ronghao},
title = {Cancer-Associated Fibroblast-Derived FGF7 Promotes Clear Cell Renal Cell Carcinoma Progression and Macrophage Infiltration},
journal = {Cells},
year = {2024},
volume = {13},
number = {22},
pages = {1824},
doi = {10.3390/cells13221824}
}
EUVIMED